Data on health economics and outcomes are complex to analyse and apply. We specialise in designing, performing and communicating these analyses with clarity and impact. We have a strong track record of abstracts and posters, many of which have garnered industry awards.
We prepare submissions that meet the constantly evolving requirements of global regulators, whose decision-making calculus we intimately understand. We ensure the success of your drug or device after all the time and money you have invested.
White papers and strategy
HEOR data are an increasingly important component of market access strategies. We work with you to prepare the internal strategy documents critical for helping your market access team make informed decisions, such as storyboards for product launches as well as analyses of patient-reported outcomes or other HTA assessment practices that sharpen your messaging. You can feel confident in our guidance because of our exceptional track record with successful HTA submissions and reimbursement strategies.
- Editorial support
- Advisory board material development
Stay in touch
Subscribe to Symmetron and stay up to date with recent news and announcements.